Cadrenal Therapeutics CEO presents at H.C. Wainwright Global Investment Conference - CVKD News | RalliesCadrenal Therapeutics CEO presents at H.C. Wainwright Global Investment Conference
C
CVKD• Conference presentation and investor meetings
- Cadrenal Therapeutics will participate in H.C. Wainwright’s 28th Annual Global Investment Conference on Sept. 14-16, 2026, in New York.
- CEO Quang X. Pham is slated to discuss the company’s cardiac acute critical care franchise and partnering plans for CAD-1005, frunexian, tecarfarin.
- Pham is also scheduled for one-on-one investor meetings during the conference.
BBY
•
